Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (94 ms)
| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1160.58/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.58 |
| Version | 20241016 |
| Status | active |
| Date | 2024-10-16T01:07:54-04:00 |
| Name | AlphaBlockerForHypertension |
| Title | Alpha Blocker for Hypertension |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts that represent medications in the Alpha Blocker pharmacologic class that are specifically indicated for the treatment of essential hypertension.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use, and prescribable medications of the Alpha Blocker pharmacologic class with a Semantic Clinical Drug (SCD) or Generic Pack (GPCK) term type that have a route of administration of: oral/pill, oral suspension, injectables, and transdermal.),(Exclusion Criteria: Excludes concepts that represent medications in the Alpha Blocker pharmacologic class with a route of administration of: ophthalmic, topical, foams, creams, and shampoo.) |
Resources that use this resource
Resources that this resource uses
Source
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1160.58",
"meta" : {
"versionId" : "8",
"lastUpdated" : "2024-11-26T11:15:08.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "HSAG Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-10-16"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2024-10-16"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.58",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1160.58"
}
],
"version" : "20241016",
"name" : "AlphaBlockerForHypertension",
"title" : "Alpha Blocker for Hypertension",
"status" : "active",
"date" : "2024-10-16T01:07:54-04:00",
"publisher" : "American Medical Association Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts that represent medications in the Alpha Blocker pharmacologic class that are specifically indicated for the treatment of essential hypertension.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use, and prescribable medications of the Alpha Blocker pharmacologic class with a Semantic Clinical Drug (SCD) or Generic Pack (GPCK) term type that have a route of administration of: oral/pill, oral suspension, injectables, and transdermal.),(Exclusion Criteria: Excludes concepts that represent medications in the Alpha Blocker pharmacologic class with a route of administration of: ophthalmic, topical, foams, creams, and shampoo.)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "1361019",
"display" : "1.7 ML phentolamine mesylate 0.235 MG/ML Cartridge"
},
{
"code" : "1361023",
"display" : "phentolamine mesylate 5 MG Injection"
},
{
"code" : "197625",
"display" : "doxazosin 1 MG Oral Tablet"
},
{
"code" : "197626",
"display" : "doxazosin 2 MG Oral Tablet"
},
{
"code" : "197627",
"display" : "doxazosin 4 MG Oral Tablet"
},
{
"code" : "197628",
"display" : "doxazosin 8 MG Oral Tablet"
},
{
"code" : "198141",
"display" : "prazosin 5 MG Oral Capsule"
},
{
"code" : "260376",
"display" : "terazosin 10 MG Oral Capsule"
},
{
"code" : "2689133",
"display" : "terazosin 1 MG/ML Oral Solution"
},
{
"code" : "312593",
"display" : "prazosin 1 MG Oral Capsule"
},
{
"code" : "312594",
"display" : "prazosin 2 MG Oral Capsule"
},
{
"code" : "313215",
"display" : "terazosin 1 MG Oral Capsule"
},
{
"code" : "313217",
"display" : "terazosin 2 MG Oral Capsule"
},
{
"code" : "313219",
"display" : "terazosin 5 MG Oral Capsule"
},
{
"code" : "636360",
"display" : "24 HR doxazosin 4 MG Extended Release Oral Tablet"
},
{
"code" : "636361",
"display" : "24 HR doxazosin 8 MG Extended Release Oral Tablet"
},
{
"code" : "861402",
"display" : "phenoxybenzamine hydrochloride 10 MG Oral Capsule"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:133fcc67-2f38-476c-a194-2e98d8da0cee",
"timestamp" : "2024-12-10T07:17:16-05:00",
"total" : 16,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1361019",
"display" : "1.7 ML phentolamine mesylate 0.235 MG/ML Cartridge"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "1361023",
"display" : "phentolamine mesylate 5 MG Injection"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "197625",
"display" : "doxazosin 1 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "197626",
"display" : "doxazosin 2 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "197627",
"display" : "doxazosin 4 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "197628",
"display" : "doxazosin 8 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "198141",
"display" : "prazosin 5 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "260376",
"display" : "terazosin 10 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "312593",
"display" : "prazosin 1 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "312594",
"display" : "prazosin 2 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "313215",
"display" : "terazosin 1 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "313217",
"display" : "terazosin 2 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "313219",
"display" : "terazosin 5 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "636360",
"display" : "24 HR doxazosin 4 MG Extended Release Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "636361",
"display" : "24 HR doxazosin 8 MG Extended Release Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "861402",
"display" : "phenoxybenzamine hydrochloride 10 MG Oral Capsule"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.
FHIR